vs
Limoneira CO（LMNR）与RECURSION PHARMACEUTICALS, INC.（RXRX）财务数据对比。点击上方公司名可切换其他公司
Limoneira CO的季度营收约是RECURSION PHARMACEUTICALS, INC.的1.2倍（$41.3M vs $35.5M），Limoneira CO净利率更高（-21.0% vs -304.2%，领先283.2%），RECURSION PHARMACEUTICALS, INC.同比增速更快（681.7% vs -2.8%），过去两年RECURSION PHARMACEUTICALS, INC.的营收复合增速更高（60.5% vs 3.8%）
Limoneira是总部位于美国加利福尼亚州的领先农业企业，主营柑橘、牛油果等特色农产品的种植、加工与分销，产品销往北美、亚洲、欧洲等市场，服务零售及餐饮客户，同时布局可持续土地开发相关业务。
Recursion Pharmaceuticals是一家临床阶段生物技术企业，依托人工智能技术和高通量生物实验体系，开发针对罕见病、肿瘤、炎症性疾病等领域未满足医疗需求的创新疗法，核心市场覆盖北美，与全球多家生物制药企业合作推进在研管线落地。
LMNR vs RXRX — 直观对比
营收规模更大
LMNR
是对方的1.2倍
$35.5M
营收增速更快
RXRX
高出684.5%
-2.8%
净利率更高
LMNR
高出283.2%
-304.2%
两年增速更快
RXRX
近两年复合增速
3.8%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $41.3M | $35.5M |
| 净利润 | $-8.7M | $-108.1M |
| 毛利率 | -15.1% | 59.8% |
| 营业利润率 | -26.8% | -304.8% |
| 净利率 | -21.0% | -304.2% |
| 营收同比 | -2.8% | 681.7% |
| 净利润同比 | -367.5% | 39.6% |
| 每股收益（稀释后） | $-0.49 | $-0.17 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收LMNRRXRX
| Q4 25 | $41.3M | $35.5M | ||
| Q3 25 | $45.9M | $5.2M | ||
| Q2 25 | $33.6M | $19.2M | ||
| Q1 25 | $32.9M | $14.7M | ||
| Q4 24 | $42.5M | $4.5M | ||
| Q3 24 | $61.8M | $26.1M | ||
| Q2 24 | $43.3M | $14.4M | ||
| Q1 24 | $38.3M | $13.8M |
净利润LMNRRXRX
| Q4 25 | $-8.7M | $-108.1M | ||
| Q3 25 | $-855.0K | $-162.3M | ||
| Q2 25 | $-3.4M | $-171.9M | ||
| Q1 25 | $-3.1M | $-202.5M | ||
| Q4 24 | $-1.9M | $-178.9M | ||
| Q3 24 | $6.6M | $-95.8M | ||
| Q2 24 | $6.6M | $-97.5M | ||
| Q1 24 | $-3.6M | $-91.4M |
毛利率LMNRRXRX
| Q4 25 | -15.1% | 59.8% | ||
| Q3 25 | 8.5% | -183.8% | ||
| Q2 25 | 5.6% | -4.9% | ||
| Q1 25 | -2.0% | -48.0% | ||
| Q4 24 | 6.3% | -181.4% | ||
| Q3 24 | 26.5% | 53.7% | ||
| Q2 24 | 6.5% | 36.2% | ||
| Q1 24 | -2.0% | 19.1% |
营业利润率LMNRRXRX
| Q4 25 | -26.8% | -304.8% | ||
| Q3 25 | -1.4% | -3327.6% | ||
| Q2 25 | -10.0% | -916.8% | ||
| Q1 25 | -16.3% | -1297.9% | ||
| Q4 24 | -6.5% | -4042.4% | ||
| Q3 24 | 14.5% | -377.1% | ||
| Q2 24 | -10.8% | -697.4% | ||
| Q1 24 | -20.2% | -698.4% |
净利率LMNRRXRX
| Q4 25 | -21.0% | -304.2% | ||
| Q3 25 | -1.9% | -3135.3% | ||
| Q2 25 | -10.0% | -894.2% | ||
| Q1 25 | -9.4% | -1373.3% | ||
| Q4 24 | -4.4% | -3935.5% | ||
| Q3 24 | 10.7% | -367.5% | ||
| Q2 24 | 15.2% | -676.6% | ||
| Q1 24 | -9.4% | -662.4% |
每股收益（稀释后）LMNRRXRX
| Q4 25 | $-0.49 | $-0.17 | ||
| Q3 25 | $-0.06 | $-0.36 | ||
| Q2 25 | $-0.20 | $-0.41 | ||
| Q1 25 | $-0.18 | $-0.50 | ||
| Q4 24 | $-0.09 | $-0.56 | ||
| Q3 24 | $0.35 | $-0.34 | ||
| Q2 24 | $0.35 | $-0.40 | ||
| Q1 24 | $-0.21 | $-0.39 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | — | $743.3M |
| 总债务越低越好 | $72.5M | $9.6M |
| 股东权益账面价值 | $180.0M | $1.1B |
| 总资产 | $311.1M | $1.5B |
| 负债/权益比越低杠杆越低 | 0.40× | 0.01× |
8季度趋势，按日历期对齐
现金及短期投资LMNRRXRX
| Q4 25 | — | $743.3M | ||
| Q3 25 | — | $659.8M | ||
| Q2 25 | — | $525.1M | ||
| Q1 25 | — | $500.5M | ||
| Q4 24 | — | $594.4M | ||
| Q3 24 | — | $427.6M | ||
| Q2 24 | — | $474.3M | ||
| Q1 24 | — | $296.3M |
总债务LMNRRXRX
| Q4 25 | $72.5M | $9.6M | ||
| Q3 25 | $63.4M | $11.9M | ||
| Q2 25 | $55.0M | $14.2M | ||
| Q1 25 | $58.0M | $16.4M | ||
| Q4 24 | $40.6M | $19.0M | ||
| Q3 24 | $40.6M | $20.5M | ||
| Q2 24 | $60.1M | $22.9M | ||
| Q1 24 | $52.1M | — |
股东权益LMNRRXRX
| Q4 25 | $180.0M | $1.1B | ||
| Q3 25 | $180.3M | $1.0B | ||
| Q2 25 | $182.7M | $919.1M | ||
| Q1 25 | $186.5M | $933.9M | ||
| Q4 24 | $191.7M | $1.0B | ||
| Q3 24 | $194.9M | $524.6M | ||
| Q2 24 | $189.0M | $584.4M | ||
| Q1 24 | $184.2M | $401.2M |
总资产LMNRRXRX
| Q4 25 | $311.1M | $1.5B | ||
| Q3 25 | $299.9M | $1.4B | ||
| Q2 25 | $296.6M | $1.3B | ||
| Q1 25 | $301.4M | $1.3B | ||
| Q4 24 | $298.8M | $1.4B | ||
| Q3 24 | $307.3M | $726.5M | ||
| Q2 24 | $322.2M | $775.9M | ||
| Q1 24 | $299.6M | $557.8M |
负债/权益比LMNRRXRX
| Q4 25 | 0.40× | 0.01× | ||
| Q3 25 | 0.35× | 0.01× | ||
| Q2 25 | 0.30× | 0.02× | ||
| Q1 25 | 0.31× | 0.02× | ||
| Q4 24 | 0.21× | 0.02× | ||
| Q3 24 | 0.21× | 0.04× | ||
| Q2 24 | 0.32× | 0.04× | ||
| Q1 24 | 0.28× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $942.0K | $-46.1M |
| 自由现金流经营现金流 - 资本支出 | — | $-47.3M |
| 自由现金流率自由现金流/营收 | — | -133.1% |
| 资本支出强度资本支出/营收 | — | 3.5% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | — | $-378.3M |
8季度趋势，按日历期对齐
经营现金流LMNRRXRX
| Q4 25 | $942.0K | $-46.1M | ||
| Q3 25 | $-3.0M | $-117.4M | ||
| Q2 25 | $8.9M | $-76.4M | ||
| Q1 25 | $-12.9M | $-132.0M | ||
| Q4 24 | $6.6M | $-115.4M | ||
| Q3 24 | $24.6M | $-59.2M | ||
| Q2 24 | $-3.0M | $-82.2M | ||
| Q1 24 | $-10.3M | $-102.3M |
自由现金流LMNRRXRX
| Q4 25 | — | $-47.3M | ||
| Q3 25 | — | $-117.6M | ||
| Q2 25 | — | $-79.6M | ||
| Q1 25 | — | $-133.8M | ||
| Q4 24 | — | $-116.7M | ||
| Q3 24 | — | $-63.8M | ||
| Q2 24 | — | $-83.4M | ||
| Q1 24 | — | $-109.0M |
自由现金流率LMNRRXRX
| Q4 25 | — | -133.1% | ||
| Q3 25 | — | -2272.5% | ||
| Q2 25 | — | -413.9% | ||
| Q1 25 | — | -907.4% | ||
| Q4 24 | — | -2567.7% | ||
| Q3 24 | — | -244.6% | ||
| Q2 24 | — | -578.5% | ||
| Q1 24 | — | -789.9% |
资本支出强度LMNRRXRX
| Q4 25 | — | 3.5% | ||
| Q3 25 | — | 4.7% | ||
| Q2 25 | — | 16.4% | ||
| Q1 25 | — | 12.4% | ||
| Q4 24 | — | 28.6% | ||
| Q3 24 | — | 17.5% | ||
| Q2 24 | — | 8.2% | ||
| Q1 24 | — | 48.2% |
现金转化率LMNRRXRX
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 3.73× | — | ||
| Q2 24 | -0.46× | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
LMNR
| Lemon Packing | $33.9M | 82% |
| Other Agribusiness | $5.8M | 14% |
| Fresh Lemons | $1.3M | 3% |
RXRX
暂无分部数据
